©2013 Baishideng Publishing Group Co., Limited. All rights reserved.
World J Virol. Nov 12, 2013; 2(4): 139-145
Published online Nov 12, 2013. doi: 10.5501/wjv.v2.i4.139
Published online Nov 12, 2013. doi: 10.5501/wjv.v2.i4.139
Does prophylactic antidepressant treatment boost interferon-alpha treatment completion in HCV?
Paul J Rowan, Division of Management, Policy, and Community Health, University of Texas Health Sciences Center at Houston School of Public Health, Houston, TX 77030, United States
Author contributions: Rowan PJ solely contributed to this paper.
Correspondence to: Paul J Rowan, PhD, MPH, Division of Management, Policy, and Community Health, University of Texas Health Sciences Center at Houston School of Public Health, 1200 Herman Pressler Drive, Houston, TX 77030, United States. prowan@uth.tmc.edu
Telephone: +1-713-5009183 Fax: +1-713-5009181
Received: April 25, 2013
Revised: August 13, 2013
Accepted: August 20, 2013
Published online: November 12, 2013
Processing time: 200 Days and 3.3 Hours
Revised: August 13, 2013
Accepted: August 20, 2013
Published online: November 12, 2013
Processing time: 200 Days and 3.3 Hours
Core Tip
Core tip: To inform clinical practice, this narrative review summarizes existing evidence regarding the degree that antidepressant prophylaxis boosts hepatitis C antiviral treatment completion compared to a rescue approach.